Redenlab
PrivateLast Round
Grant
Sep 22, 2025
Total Funding Raised
$1.64M
Company Overview
Redenlab operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Grant round in September 2025.
Redenlab is a health technology company that provides speech and language biomarker analysis to enhance decision-making in clinical trials and healthcare research.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, NLP & Conversational AI, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Redenlab Comparables
Compare Redenlab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ki:elements GmbH | 89% | |
| Novoic | 85% | |
| Cumulus Neuroscience | 84% |
For institutional investors. Book with your work email.
Redenlab Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Redenlab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors increased 57% MoM.
- Jan 21, 2025
Grew 16% QoQ, from 25 to 29 employees.
For institutional investors. Book with your work email.
Redenlab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Redenlab's valuation, stock price, and market status.
Is Redenlab a public or private company?
Redenlab is a private company.
What is the current stock price of Redenlab?
Redenlab is a private company, so its shares have no public market price. Caplight tracks Redenlab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Redenlab worth (valuation)?
Valuation information for Redenlab is not publicly available.
Can I buy Redenlab stock?
Redenlab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Redenlab's last funding round?
Redenlab's most recent funding round was Grant on September 22, 2025.
Who are the main investors in Redenlab?
Key investors in Redenlab include CUREator.
Will Redenlab IPO soon?
No public IPO plans have been announced for Redenlab.
How can I track Redenlab secondary market activity?
Caplight tracks bids, offers, and trades in Redenlab's shares on secondary markets.